Science
Mechanism of Action
This hexapeptide is structurally derived from Alpha-Latrotoxin-Lt1a, a neurotoxin known to induce substantial neurotransmitter release, depolarize neuronal membranes, elevate intracellular Ca2+ levels in nerve terminals, and form ion-permeable pores in lipid membranes. However, the precise mechanism by which S-BLACK WIDOW SPIDER HEXAPEPTIDE-1 SP exerts any effect on the skin within a cosmetic formulation has not been detailed in available research.
Research
Clinical Evidence
Insufficient-data confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
General spider venom peptides often demonstrate notable thermal, chemical, and enzymatic resilience, frequently due to stabilizing disulfide bonds or cystine knot structures. However, specific stability information for S-BLACK WIDOW SPIDER HEXAPEPTIDE-1 SP in cosmetic applications is not available.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) noted the existence of 's-Black Widow Spider Hexapeptide-1 SP' as a 6-amino acid peptide derived from Alpha-Latrotoxin-Lt1a. However, the CIR has not conducted a safety assessment, thus no official safety status (e.g., safe as used, safe with restrictions, insufficient data, or not reviewed) or maximum allowable concentration has been established. No specific opinions from SCCS or status from the FDA were found.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to the complete absence of clinical studies, an undefined cosmetic mechanism of action, and an unreviewed safety status, there is currently insufficient data to determine the efficacy or safety of S-BLACK WIDOW SPIDER HEXAPEPTIDE-1 SP for skincare use.
Related
Similar Ingredients
Finding similar ingredients…